Pharma

2024 - 12 - 20

Post cover
Image courtesy of "Pharmaceutical Executive"

Pharma Pulse 12/20/24: Trends in Enterprise Value Growth and ... (Pharmaceutical Executive)

Anna-Maria Hoffmann-Vold, MD, PhD, discusses progressive pulmonary fibrosis, its primary causes and the key risk factors contributing to its development and ...

Pharma Shifts to Needle-Free Injectors: Microneedle Devices Set for ... (Business Wire)

The needle-free drug injection system market is expected to reach USD 606 million in the current year and is anticipated to grow at a CAGR of 4% to 2035.

Post cover
Image courtesy of "Radio Canada International (en)"

Canadian health plans, pharma firm agree on terms to fund costly ... (Radio Canada International (en))

An organization representing Canada's public drug plans has come to a deal with a pharmaceutical company over a cutting-edge means of treating prostate ...

Post cover
Image courtesy of "PharmaLive"

Five data-driven media planning principles for pharma marketers in ... (PharmaLive)

When it comes to media strategy, the line between “spending” and “investing” can be as hazy as a misty morning. The difference? Spending is throwing money ...

Post cover
Image courtesy of "Business Wire"

TME Pharma Provides Results of Fourth Exercise of Warrants Z (Business Wire)

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea.

Explore the last week